Trial Details
TERMINATEDBasic Information
| Clinical ID | c734 |
|---|---|
| Identifier | NCT06137183 |
| Trial Title | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Vixarelimab|DRUG: Placebo |
Participant Information
| Sponsor | Genentech, Inc. |
|---|---|
| City | Camarillo |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2024-05-01 |
|---|---|
| Primary Completion Date | 2025-06-16 |
| Completion Date | 2025-06-16 |